Albemarle (ALB) Appoints Former Wyeth President Joseph Mahady to Board
Tweet
Share
E-mailGet Alerts ALB Hot Sheet
Join SI Premium – FREE
Albemarle Corporation (NYSE: ALB) announced today that its board of directors has elected Joseph M. Mahady to the company's board, effective February 1, 2012.
In 2009, Mahady retired from Wyeth Corporation, a global manufacturer of pharmaceutical products, following its acquisition by Pfizer (NYSE: PFE) and after 30 years with the company. At the time of his retirement, Mahady served as president – Wyeth Pharmaceuticals.
In 2009, Mahady retired from Wyeth Corporation, a global manufacturer of pharmaceutical products, following its acquisition by Pfizer (NYSE: PFE) and after 30 years with the company. At the time of his retirement, Mahady served as president – Wyeth Pharmaceuticals.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- Boston Beer CFO Diego Reynoso to depart; Matt Murphy named interim
- Ramaco Resources names new CAO and general counsel
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
